http://www.akebia.com
Akebia Therapeutics, Inc. Company Intro
Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.
Industry
Healthcare
Akebia Therapeutics, Inc. Headquaters
245 First Street
Cambridge,02142
United States
Akebia Therapeutics, Inc. Share price
26 Oct 2020 01:03 GMT
$3.3442
0.06 (1.96 %)
Akebia Therapeutics, Inc. Market cap
$455.748 M
WMC RANKING
2020
Akebia Therapeutics, Inc. # 20
BiotechnologyLatest Akebia Therapeutics, Inc. News
25 Oct 2020
Iron Deficiency Anemia Therapy Market 2020 Segmentation ...
... Akebia Therapeutics; AMAG Pharmaceuticals; Keryx Biopharmaceuticals Inc. Luitpold Pharmaceuticals Inc. Johnson & Johnson; Pharmacosmos AS; Pieris ...
26 Oct 2020
Think You Need A Good Stock? Look At This Akebia Therapeutics, Inc. (NASDAQ:AKBA) Analysis
Akebia Therapeutics, Inc. (NASDAQ:AKBA) traded at $3.18 at last check on Friday, Oct ... The company's stock has gained about 29.27% over that past 30 days.
26 Oct 2020
Akebia Therapeutics Inc. (AKBA) and ZIOPHARM Oncology Inc. (ZIOP) Have A Decent Quarter, Future Looks Brighter
SIMPLEX TRADING LLC bought a fresh place in Akebia Therapeutics Inc. (NASDAQ:AKBA). The institutional investor bought 52.8 thousand shares of the stock ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Akebia Therapeutics, Inc. | 5.88 | 1.87 | 12.02 | 0 | 0 | 0 | 10.41 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.29 | 100 | 20 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.09 | 26 | 0 | 0 | 97.35 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 2.78 |
| Incyte Corporation | 40.27 | 14.26 | 7.21 | 100 | 0 | 0 | 90.91 |
Akebia Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Akebia Therapeutics, Inc. | $325,296 | $491,894 | $-245,230 | $455.748M | 20 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.654B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.11B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.42B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.615B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Akebia Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Akebia Therapeutics, Inc. Post vs Top 4 Industry Competitors
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
